Lexicon Pharmaceuticals | LXRX - Текущие обязательства





Текущие обязательства Изменить Дата
Abbott USD 18.38B 1.88B 2026-03
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
Agios Pharmaceuticals USD 58.84M 23.36M 2026-03
Akebia Therapeutics USD 162.94M 29.56M 2025-12
Alnylam Pharmaceuticals USD 1.35B 116.87M 2026-03
AstraZeneca USD 32.57B 1.95B 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Coherus Biosciences USD 140.39M 231.91M 2025-12
Eli Lilly USD 36.63B 1.41B 2026-03
Esperion Therapeutics USD 300.81M 58.22M 2025-12
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
Illumina USD 1.57B 19M 2026-03
Insmed USD 468.87M 51.66M 2025-12
Ironwood Pharmaceuticals USD 242.5M 9.98M 2025-09
J&J USD 57.72B 3.59B 2026-03
Lexicon Pharmaceuticals USD 20.87M 853K 2025-12
MacroGenics USD 43.11M 1.36M 2025-12
MannKind USD 171.03M 61.9M 2025-12
Merck USD 26.94B 1.38B 2026-03
Moderna USD 2.4B 408M 2026-03
Novartis USD 31.37B 4.1B 2026-03
PTC Therapeutics USD 968.43M 102.18M 2025-12
Puma Biotechnology USD 82.73M 3.63M 2025-09
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Thermo Fisher Scientific USD 14.62B 568M 2026-03
Ultragenyx Pharmaceutical USD 325M 59M 2026-03
United Therapeutics USD 599.1M 38.5M 2026-03
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12